Prevent Cancer Foundation to join Fight Colorectal Cancer at the White House to address colorectal cancer screening needs
ZUR SOFORTIGEN VERÖFFENTLICHUNG
Kyra Meister
703-836-1746
kyra.meister@preventcancer.org
Washington, DC – Earlier this year, President Biden reignited the Cancer Moonshot with renewed leadership and ambitious goals to ‘end cancer as we know it.’ To address colorectal cancer, the White House has been working with national advocacy organization Fight Colorectal Cancer (Fight CRC) and other advocacy and industry leaders in the colorectal cancer community. On July 25, 2022, Carolyn “Bo” Aldigé, founder of Die Stiftung zur Krebsvorbeugung, and 18 others will join Fight CRC at the White House to discuss their shared response to the President’s call to action to improve and increase access to colorectal cancer screening, with a special emphasis on reaching the underserved and the 44 million people who need to be screened.
“The hope is that we can find and agree on a collective strategy and tangible steps we can take to get more people screened for colorectal cancer. We applaud the Administration and the White House for including a specific call to action on cancer screening and early detection within the Cancer Moonshot initiative,” said Bo Aldigé.
Although colorectal cancer is preventable with rechtzeitig screening and highly treatable if caught early, one in three people are not up-to-date with colorectal cancer screening. This was exacerbated by the COVID-19 pandemic—a January 2022 survey conducted by the Prevent Cancer Foundation found that one-half of Americans who had a scheduled in-person medical appointment missed, postponed and/or cancelled one or more of these appointments over the past two years. Despite the availability of several safe and effective colorectal cancer screening options, colorectal cancer remains the number two cause of death for men and women combined, with communities of color experiencing even higher incidence and mortality rates.
“We commend the bold vision to fight cancer by President Biden and the Moonshot program,” said Anjee Davis, President of Fight CRC. “It is our hope as catalysts for the colorectal cancer community that with this meeting, we can address inequities within colorectal cancer screening and make progress toward our Path to a Cure. Prevention plays a huge role in ending colorectal cancer. The White House asked for a plan to get more people screened, and we are here to deliver—leading with the power of the patient voice.”
Participants who will be attending the White House Meeting:
Carolyn “Bo” Aldigé – Prevent Cancer Foundation, Founder
Alexey Aleshin, MD – Natera, General Manager, Early Cancer Detection
Andrew Barnell, MBA – Geneoscopy Inc., CEO
Danielle Carnival, PhD – White House Cancer Moonshot, Coordinator
Austin Chiang, MD, MPH – Medtronic, CMO
Kevin Conroy – Exact Sciences, CEO
Anjee Davis, MPPA – Fight Colorectal Cancer, President
AmirAli Talasaz, PhD – Guardant Health, Co-CEO
Greg Hamilton, MBA – Epigenomics, CEO
Lisa Lacasse – American Cancer Society Cancer Action Network (ACS CAN), President
David Lieberman, MD, AGAF – American Gastroenterological Association, Former President
Molly McDonnell – Fight Colorectal Cancer, Director of Advocacy
Arif Nathoo, MD, MPA – Komodo Health, Co-Founder & CEO
Angela Nicholas, MD – Fight Colorectal Cancer, Board Member
Mike Nolan, MBA – Freenome, CEO
AmirAli Talasaz, PhD – Guardant Health, Co-CEO
Catharine Young, MPA – Office of Science & Technology Policy (OSTP), Senior Director
The meeting will be closed; however, for photos, b-roll or official comments before or after the roundtable, please contact media@fightcrc.org oder kyra.meister@preventcancer.org.
###
About Fight Colorectal Cancer
Fight Colorectal Cancer (Fight CRC) is a leading patient-empowerment and advocacy organization in the United States, providing balanced and objective information on colon and rectal cancer research, treatment, and policy. They are relentless champions of hope, focused on funding promising, high-impact research endeavors while equipping advocates to influence legislation and policy for the collective good. Learn more at FightCRC.org.
Über die Prevent Cancer Foundation®
Die Stiftung Prevent Cancer® ist die einzige gemeinnützige Organisation in den USA, die sich ausschließlich darauf konzentriert, Leben aller Bevölkerungsgruppen durch Krebsvorsorge und Früherkennung zu retten. Durch Forschung, Aufklärung, Öffentlichkeitsarbeit und Interessenvertretung haben wir unzähligen Menschen geholfen, eine Krebsdiagnose zu vermeiden oder ihren Krebs früh genug zu erkennen, um erfolgreich behandelt werden zu können.
Die Stiftung stellt sich der Herausforderung, die Zahl der Krebstoten bis 2035 um 401 TP3T zu senken. Um dieses Ziel zu erreichen, haben wir uns verpflichtet, 1 TP4T20 Millionen in innovative Technologien zur Krebsfrüherkennung und zur Verbesserung des Multi-Krebs-Screenings zu investieren, 1 TP4T10 Millionen in die Ausweitung des Zugangs zu Krebsscreenings und Impfungen auf medizinisch unterversorgte Gemeinden und 1 TP4T10 Millionen in die Aufklärung der Öffentlichkeit über Screening- und Impfmöglichkeiten.
Für weitere Informationen, besuchen Sie bitte www.preventcancer.org.